Flow cytometric evaluation of red blood cells transformed with variable amounts of synthetic A and B glycolipids by Hult, K et al.
Flow Cytometric Evaluation of Red Blood Cells Transformed with Variable 
Amounts of Synthetic A and B Glycolipids 
A.K. Hult1, T. Frame2, S. Henry3, M.L. Olsson1
1. Department of Laboratory Medicine, Lund University & Blood Centre, University Hospital, Lund, Sweden
2. ImmucorGamma, Norcross, Georgia, USA 
3. Biotechnology Research Institute, AUT University, Auckland, New Zealand
Background Materials & Methods
According to national guidelines or directives, monoclonal ABO reagents may be 
required to detect Ax and Bweak subgroup red blood cells (RBCs). Many routine 
laboratories do not have access to naturally-occurring ABO subgroups that can 
be used as weak controls for these reagents. Group O RBCs modified with 
synthetic analogs of blood group A and/or B glycolipids (KODETM technology) to 
mimic weak ABO subgroups could be used for quality control purposes. 
Samples: KODETM RBCs were prepared according to a previously described 
procedure.1 RBCs were modified with 15 different concentrations of synthetic 
glycolipids, ranging from 1000 µg/mL to 0.06 µg/mL for KODETM-A and 5000 µg/mL 
to 0.3 µg/mL for KODETM-B. The concentration was decreased by doubling dilution 
steps. For both KODETM-A and KODETM-B RBCs, repeat samples were produced 
for four selected concentrations as a consistency measurement and all KODETM
b t h t t d i t i li t
Aim of the Study
Extensive serological testing of KODETM RBCs has previously been carried out. 
An extended evaluation of KODETM RBCs using flow cytometry was performed 
to explore the correlation between the concentrations of synthetic glycolipids and 
A/B antigen site density of the resulting RBCs. The aim of this study was to 
examine if KODETM RBCs mimic the distinct flow cytometric patterns of 
naturally-occurring ABO subgroups and to identify the optimal concentration of 
glycolipid required.
a c es were es e  n r p ca e. 
Flow Cytometry: Sensitive and specific flow cytometry was used to characterize 
and semiquantify the synthetic A and B antigen levels on group O RBCs. Relevant 
control RBCs (A1, A2, Ax, B, Bweak and O) were included in each run. 
Primary antibodies: Anti-A (ES-15, Serologicals Limited, West Lothian, UK) Anti-B 
(9621A8, Diagast, France). Secondary antibody: PE-labelled rat-anti-mouse Ig 
kappa light chain (Becton Dickinson, CA, USA). 
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Figure 2. Colour code: 
Red represent the 
KODETM-B samples 
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dot plots and histograms. 
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Results Conclusion
Flow cytometric testing of KODETM RBCs modified with high concentrations of Using very low amounts of synthetic glycolipids KODETM-A and KODETM-B RBCs
   
with low amounts of 
synthetic glycolipids. Of all 
KODETM–A samples tested 
they displayed the flow 
cytometric pattern with 
most resemblance to the 
naturally-occuring ABO 
subgroup Ax.
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shows the flow cytometric 
pattern most resembling 
the naturally-occuring 
ABO subgroup Bw used in 
this study.
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synthetic glycolipids revealed a uniform and even distribution of antigens in the 
cell population as shown by a single narrow peak in the FACS histograms. When 
lower concentrations were used, peaks tended to broaden to a pattern found in Ax
and most B subgroups indicating a more variable antigen site density on the cells 
in the population. The concentrations of synthetic glycolipids which produced 
KODETM cells that resembled the naturally-occurring subgroup control RBCs 
used in this study are ~2-4 µg/mL for KODETM-A and ~10 µg/mL for KODETM-B. 
Repeat testing demonstrated good correlation between flow cytometric runs and 
KODETM batches.
      ,     
can be made to mimic Ax and Bweak subgroup control RBCs, respectively, according 
to this flow cytometric study. With higher concentrations of synthetic glycolipids, the 
KODETM RBCs demonstrated a more uniform and even distribution of antigens 
among the cells. This is in contrast to naturally-occurring subgroups in which some 
cells express almost no A or B antigen whilst others have close to normal levels. 
The reason for this is unknown. KODETM RBCs obviously lack A/B-carrying 
glycoproteins but it is not fully understood to what extent glycolipid versus 
glycoprotein A/B epitopes contribute to the phenotype of weak subgroups.
This study indicates that KODETM RBCs with weak expression of A and/or B 
antigen have characteristics compatible with use as quality controls for monoclonal 
ABO reagents and could be a valuable addition in the serological laboratory
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